Skip to main content
TTRX
NASDAQ Life Sciences

Turn's GX-03 shows significant disease reduction in peer-reviewed preclinical data

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$5.37
Mkt Cap
$159.664M
52W Low
$2.57
52W High
$26.5
52W Position info
109% above low
Off High info
80% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

TTRX has more than doubled off its 52-week low of $2.57 on elevated volume (2.0× avg).

Summary

Turn Therapeutics announced positive peer-reviewed preclinical data for its drug candidate GX-03, demonstrating a statistically significant reduction in disease severity in an IL-36 associated murine dermatitis model. This news follows an 8-K filed earlier today regarding the publication. The positive data provides further scientific validation for GX-03, which is currently in a Phase 2 trial. Topline results from the Phase 2 trial are expected mid-2026, which will be a key event to watch.

At the time of this announcement, TTRX was trading at $5.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $159.7M. The 52-week trading range was $2.57 to $26.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

TTRX - Latest Insights

TTRX
Nov 16, 2026, 4:23 PM EST
Filing Type: 424B3
Importance Score:
7
Price at Filing: $8.55
Real-time Price: $8.64 info
Change: +$0.090 (+1%) info
Market Cap: $264.148M info
TTRX
Nov 10, 2026, 8:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $9.79
Real-time Price: $8.64 info
Change: -$1.15 (-12%) info
Market Cap: $264.148M info
TTRX
Nov 09, 2026, 8:05 AM EST
Filing Type: S-3
Importance Score:
7
Price at Filing: $9.48
Real-time Price: $8.64 info
Change: -$0.840 (-9%) info
Market Cap: $264.148M info
TTRX
Nov 09, 2026, 8:00 AM EST
Filing Type: S-3
Importance Score:
8
Price at Filing: $9.48
Real-time Price: $8.64 info
Change: -$0.840 (-9%) info
Market Cap: $264.148M info
TTRX
Nov 09, 2026, 7:02 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $9.48
Real-time Price: $8.64 info
Change: -$0.840 (-9%) info
Market Cap: $264.148M info